ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,093Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 252

$663K Total Retail Price of All Prescriptions

Rank: 56 out of 252

281 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 281 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 281 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 9,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
DONEPEZIL HCL 790 713 1 28
NAMENDA 767 705 2 41
LEVOTHYROXINE SODIUM 442 410 3 1
WARFARIN SODIUM 399 399 4 14
FUROSEMIDE 357 322 5 7
SIMVASTATIN 356 311 6 2
LISINOPRIL 305 256 7 3
METOPROLOL TARTRATE 278 257 8 10
HYDROCODONE-ACETAMINOPHEN 267 249 S3 9 5
SERTRALINE HCL 221 213 10 27
LANTUS 220 162 11 55
TRAZODONE HCL 216 178 12 31
ALENDRONATE SODIUM 209 178 13 32
AMLODIPINE BESYLATE 175 148 14 4
ATENOLOL 173 150 15 18
POTASSIUM CHLORIDE 167 143 16 8
MIRTAZAPINE 165 154 17 58
CITALOPRAM HBR 152 125 18 15
NOVOLOG 141 87 19 106
TAMIFLU 125 109 20 249
GABAPENTIN 123 104 21 11
DIVALPROEX SODIUM 118 74 22 113
OMEPRAZOLE 101 92 23 6
PRAVASTATIN SODIUM 99 90 24 12
DIGOXIN 98 98 25 44
ABILIFY 94 82 26 185
RISPERIDONE 94 76 26 81
CARVEDILOL 91 78 28 22
IPRATROPIUM-ALBUTEROL 90 68 29 155
EXELON 86 86 30 154
LANTUS SOLOSTAR 82 77 31 109
NYSTATIN 79 69 32 171
CHLORTHALIDONE 78 73 33 141
LEVETIRACETAM 76 25 34 131
OXYCODONE HCL 75 49 S2 35 89
ATORVASTATIN CALCIUM 75 69 35 16
NOVOLOG FLEXPEN 73 46 37 195
METFORMIN HCL 72 46 38 9
TRAMADOL HCL 72 70 38 17
SEROQUEL 67 48 40 149
HUMALOG 65 59 41 226
ESCITALOPRAM OXALATE 64 64 42 56
CIPROFLOXACIN HCL 63 55 43 61
METOPROLOL SUCCINATE 59 53 44 19
TAMSULOSIN HCL 56 27 45 26
ADVAIR DISKUS 56 55 45 63
DIOVAN 55 55 47 38
LEVOFLOXACIN 53 46 48 79
PAROXETINE HCL 52 20 49 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.